<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>622</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15468058</PubmedId>
            <Abstract>HLA-A2.1-/HLA-DR1-transgenic H-2 class I-/class II-knockout mice were created and their immunological potential evaluated in response to hepatitis B DNA vaccine. Every single immunized mouse developed hepatitis B virus-specific antibodies, HLA-DR1-restricted helper, and HLA-A2.1-restricted cytolytic T cell responses directed at the same immunodominant epitopes as those identified in naturally infected or vaccinated humans. These mice were specifically protected against a hepatitis B-recombinant vaccinia virus infection with a 10,000-fold or more reduction of the virus load at day 4 post-challenge. These mice represent a unique in vivo experimental model for human immune function studies without any interference with mouse MHC response which dwarfed the prediction of human responses. Furthermore, they enable the complete monitoring of immune adaptative responses for preclinical screening of candidate vaccines.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>3060-9</ArticlePages>
            <ArticleTitle>A mouse model of human adaptive immune functions: HLA-A2.1-/HLA-DR1-transgenic H-2 class I-/class II-knockout mice.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Pajot</LastName>
                    <ForeName>Anthony</ForeName>
                </Author>
                <Author>
                    <LastName>Michel</LastName>
                    <ForeName>Marie-Louise</ForeName>
                </Author>
                <Author>
                    <LastName>Fazilleau</LastName>
                    <ForeName>Nicolas</ForeName>
                </Author>
                <Author>
                    <LastName>Pancré</LastName>
                    <ForeName>Véronique</ForeName>
                </Author>
                <Author>
                    <LastName>Auriault</LastName>
                    <ForeName>Claude</ForeName>
                </Author>
                <Author>
                    <LastName>Ojcius</LastName>
                    <ForeName>David M</ForeName>
                </Author>
                <Author>
                    <LastName>Lemonnier</LastName>
                    <ForeName>François A</ForeName>
                </Author>
                <Author>
                    <LastName>Lone</LastName>
                    <ForeName>Yu-Chun</ForeName>
                </Author>
            </Authors>
            <Affiliations>Unité d'Immunité Cellulaire Antivirale, Département d'Immunologie, Institut Pasteur, Paris, France.</Affiliations>
            <ArticleChemicalList>Antibodies, Viral;H-2 Antigens;HLA-A2 Antigen;HLA-DR1 Antigen;Hepatitis B Surface Antigens;Hepatitis B Vaccines;Vaccines, DNA</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Animals; Antibodies, Viral(blood); Flow Cytometry; Genes, MHC Class I(immunology); H-2 Antigens(genetics; immunology); HLA-A2 Antigen(genetics; immunology); HLA-DR1 Antigen(genetics; immunology); Hepatitis B(immunology; prevention &amp; control); Hepatitis B Surface Antigens(immunology); Hepatitis B Vaccines(immunology); Hepatitis B virus(immunology); Humans; Immunophenotyping; Mice; Mice, Knockout; Mice, Transgenic; Models, Animal; Molecular Sequence Data; Vaccination; Vaccines, DNA(immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>34</Volume>
                <Issue>11</Issue>
                <Title>European journal of immunology</Title>
                <Issn>0014-2980</Issn>
                <MedlineTa>Eur J Immunol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>HBsAg348-357</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GLSPTVWLSV</LinearSequence>
                        <StartingPosition>348</StartingPosition>
                        <EndingPosition>357</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03138.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10407</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Methods 4.5</LocationOfData>
                <EpitopeId>21139</EpitopeId>
                <ReferenceStartingPosition>348</ReferenceStartingPosition>
                <ReferenceEndingPosition>357</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Previously characterized dominant HLA-A2 restricted epitope.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <TCellId>5852</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000080</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Major surface antigen precursor</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>50 μg in each side of regenerating tibialis anterior muscles.</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>GLSPTVWLSV</LinearSequence>
                                            <StartingPosition>348</StartingPosition>
                                            <EndingPosition>357</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>The immunogen is a plasmid encoding for preS2 and S-Antigen (HBV vaccine) Animals were sacrificed 12 days post immunization.  Splenocytes were incubated with peptide-pulsed, γ-irradiated LPS blast cells for 7 days prior to evaluation of CTL activity.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>RMA-lymphocyte</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>143</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HBsAg348-357</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GLSPTVWLSV</LinearSequence>
                                        <StartingPosition>348</StartingPosition>
                                        <EndingPosition>357</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P03138.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10407</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>40.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>6</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Efficient recognition of HHD-expressing target cells loaded with this peptide is obtained from splenocytes from HHD (HLA-A2.1/Db) + HLA-DR1 transgenic, H-2 class I / H-2 class II knock-out C57BL/6 mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HBsAg179-194</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>QAGFFLLTRILTIPQS</LinearSequence>
                        <StartingPosition>179</StartingPosition>
                        <EndingPosition>194</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03138.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10407</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Methods 4.5</LocationOfData>
                <EpitopeId>50262</EpitopeId>
                <ReferenceStartingPosition>179</ReferenceStartingPosition>
                <ReferenceEndingPosition>194</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <TCellId>1274443</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000080</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Major surface antigen precursor</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>50 μg in each side of regenerating tibialis anterior muscles.</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>QAGFFLLTRILTIPQS</LinearSequence>
                                            <StartingPosition>179</StartingPosition>
                                            <EndingPosition>194</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>The immunogen is a plasmid encoding for preS2 and S-Antigen (HBV vaccine) Animals were sacrificed 12 days post immunization.  Splenocytes were incubated with peptide-pulsed, γ-irradiated LPS blast cells for 7 days prior to evaluation of CTL activity.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Blast Activated</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>327</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HBsAg179-194</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QAGFFLLTRILTIPQS</LinearSequence>
                                        <StartingPosition>179</StartingPosition>
                                        <EndingPosition>194</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P03138.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10407</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>6</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Peptide stimulation of  restimulated splenocytes from HHD (HLA-A2.1/Db) + HLA-DR1 transgenic, H-2 class I / H-2 class II knock-out C57BL/6 mice immunized with a plasmid containing the major surface antigen sequence leads to specific proliferative responses.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HBsAg109-134</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MQWNSTTFHQTLQDPRVRGLYFPAGG</LinearSequence>
                        <StartingPosition>109</StartingPosition>
                        <EndingPosition>134</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03138.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10407</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Methods 4.5</LocationOfData>
                <EpitopeId>42443</EpitopeId>
                <ReferenceStartingPosition>109</ReferenceStartingPosition>
                <ReferenceEndingPosition>134</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <BCellId>5855</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000080</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Major surface antigen precursor</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>50 μg in each side of regenerating tibialis anterior muscles. Animals were sacrificed 12 days later.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The immunogen is a plasmid encoding for preS2 and S-Antigen (HBV vaccine). Sera was obtained 12 days post immunization.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>6</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>HBsAg109-134</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MQWNSTTFHQTLQDPRVRGLYFPAGG</LinearSequence>
                                        <StartingPosition>109</StartingPosition>
                                        <EndingPosition>134</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P03138.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10407</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HBsAg335-343</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>WLSLLVPFV</LinearSequence>
                        <StartingPosition>335</StartingPosition>
                        <EndingPosition>343</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03138.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10407</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Methods 4.5</LocationOfData>
                <EpitopeId>72794</EpitopeId>
                <ReferenceStartingPosition>335</ReferenceStartingPosition>
                <ReferenceEndingPosition>343</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Previously characterized subdominant HLA-A2 restricted epitope.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <TCellId>1274444</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000080</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Major surface antigen precursor</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>50 μg in each side of regenerating tibialis anterior muscles.</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>WLSLLVPFV</LinearSequence>
                                            <StartingPosition>335</StartingPosition>
                                            <EndingPosition>343</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>The immunogen is a plasmid encoding for preS2 and S-Antigen (HBV vaccine) Animals were sacrificed 12 days post immunization.  Splenocytes were incubated with peptide-pulsed, γ-irradiated LPS blast cells for 7 days prior to evaluation of CTL activity.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>RMA-lymphocyte</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>143</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HBsAg335-343</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>WLSLLVPFV</LinearSequence>
                                        <StartingPosition>335</StartingPosition>
                                        <EndingPosition>343</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P03138.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10407</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>40.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>6</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Efficient recognition of HHD-expressing target cells loaded with this peptide is obtained from splenocytes from HHD (HLA-A2.1/Db) + HLA-DR1 transgenic, H-2 class I / H-2 class II knock-out C57BL/6 mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

